BioNTech, Moderna Stocks Crumble As Booster Opportunity Stands On Shaky Ground

Vaccine stocks BioNTech (BNTX) and Moderna (MRNA) toppled Friday after a Food and Drug Administration panel appeared to be leaning against Covid booster shots.
XEvercore ISI analyst Umer Raffat doesn’t expect the FDA advisory committee to vote in support…

Click here to view the original article.